UHAC62XX Tablets

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UHAC62XX Tablets, covering 2014-07-14 to 2014-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of UHAC62XX Tablets Compared With Capsules in Healthy Volunteers [Phase 1]